Steven Mah's Stock Ratings

TD Cowen Analyst

Steven Mah is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/17/2024

Overall Average Return

12.1%

Smart Score

57.5%

Overall Average Return Percentile

65th

Number of Ratings

12
Buy NowGet Alert
07/17/2024BLFSBuy Now
BioLife Solns
$23.0112.99%$20 → $26MaintainsBuyGet Alert
06/13/2024TWSTBuy Now
Twist Bioscience
$56.4515.15%$55 → $65MaintainsBuyGet Alert
03/01/2024DNABuy Now
Ginkgo Bioworks Holdings
$0.34787.31%$7 → $3MaintainsOutperformGet Alert
01/26/2024RXRXBuy Now
Recursion Pharmaceuticals
$8.36——Initiates → Market PerformGet Alert
01/26/2024SDGRBuy Now
Schrodinger
$23.3280.1% → $42Initiates → OutperformGet Alert
08/23/2023CELLBuy Now
PhenomeX
—— → $1DowngradeOutperform → Market PerformGet Alert
02/28/2023ABCLBuy Now
AbCellera Biologics
$3.40——Initiates → OutperformGet Alert
02/22/2023OABIBuy Now
OmniAb
$4.84106.4% → $10Initiates → OutperformGet Alert
09/22/2022MEBuy Now
23andMe Holding
$0.521055.18% → $6Initiates → OutperformGet Alert
08/12/2022ABSIBuy Now
Absci
$4.28——UpgradeMarket Perform → OutperformGet Alert
07/15/2022CDXSBuy Now
Codexis
$3.47505.08%$39 → $21MaintainsOutperformGet Alert
03/02/2022DNABuy Now
Ginkgo Bioworks Holdings
$0.343449.25% → $12Initiates → OutperformGet Alert